Crohn's Disease Clinical Trial
Official title:
MICISPORT Patient Questionnaire
This study offers a questionnaire to patients with Crohn's disease in order to assess their physical activity and / or sport as well as their eating habits in order to assess the impact of these lifestyle habits on activity and the symptoms of the disease.
This questionnaire, validated with Doctor Pineton de Chambrun, is set up within the framework
of an exercise thesis in pharmacy focusing on the impact of physical activity and diet on the
evolution and patients' Crohn's disease (CD) experience. Along with ulcerative colitis (UC),
Crohn's disease belongs to chronic inflammatory bowel disease (IBD), which is a major public
health concern. These pathologies currently affect 2.5 million patients in Europe (1 million
of CD versus 1.5 million of UC). More specifically, in France in 2015, there were 212,700
patients with IBD, with a proportion of 60% CD and 40% RCH1. These pathologies have a major
impact on patient's lifes, both in terms of quality of life and the therapeutic course
(efficacy and side effects).
Physical activity and diet are other important concerns of health authorities. They are the
subject of numerous recommendations based on age and health status. The World Health
Organization (WHO), for example, recommends that adults between the ages of 18 and 64 should
practice endurance physical activity of moderate intensity lasting at least 150 minutes per
week or 75 minutes per day, sustained intensity endurance activity, or a combination of these
two types of activity. Epidemiological data show that the lack of physical activity and a
sedentary lifestyle favor the increase of the prevalence of diseases, such as cancer and
diabetes, but also the increase in cardiovascular risk factors, such as hypertension, obesity
and hyperglycemia. A sedentary lifestyle is also considered to be the fourth risk factor for
mortality worldwide. Therefore, it appears interesting to study the potential impact of
physical activity and exercise as well as food consumption on the activity of Crohn's
disease. This impact felt by patients will be assessed by means of a questionnaire which will
be offered to them after their medical consultation. The hypothesis of this work is that
physical activity and / or sports and diet control improve the quality of life for patients
with Crohn's disease.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03815851 -
Relationship Between Prophylactic Drainage and Postoperative Complications (PPOI) in Crohn's Patients After Surgery
|
N/A | |
| Not yet recruiting |
NCT06100289 -
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
|
Phase 3 | |
| Completed |
NCT02883452 -
A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis
|
Phase 1 | |
| Recruiting |
NCT04777656 -
Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Crohn's Disease Patients.
|
Phase 3 | |
| Terminated |
NCT03017014 -
A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions
|
||
| Recruiting |
NCT06053424 -
Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Healthy Participants and Patients With Crohn's Disease
|
Phase 1 | |
| Recruiting |
NCT05428345 -
A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
|
||
| Completed |
NCT02508012 -
Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases
|
N/A | |
| Not yet recruiting |
NCT02858557 -
The Effect of Diet on Microbial Profile and Disease Outcomes in Patients With Inflammatory Bowel Diseases
|
N/A | |
| Terminated |
NCT02882841 -
MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients
|
N/A | |
| Completed |
NCT02542917 -
Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study
|
||
| Terminated |
NCT02417974 -
Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)
|
Phase 2 | |
| Completed |
NCT03010787 -
A First Time in Human Study in Healthy Volunteers and Patients
|
Phase 1 | |
| Active, not recruiting |
NCT02316678 -
Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics
|
N/A | |
| Completed |
NCT02197780 -
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
|
N/A | |
| Completed |
NCT02193048 -
Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease
|
||
| Completed |
NCT02265588 -
Healthy Approach to Physical and Psychological Problems in Youngsters With IBD (HAPPY-IBD).
|
N/A | |
| Completed |
NCT02154425 -
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
|
Phase 1 | |
| Recruiting |
NCT02395354 -
Comparative Prospective Multicenter Randomized Study of Endoscopic Treatment of Stenosis in Crohn´s Disease
|
N/A | |
| Completed |
NCT01958827 -
A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's Disease
|
Phase 3 |